News Feed

Scientists have achieved a major milestone in neuroscience by mapping every neural connection in the central nervous system of an adult fruit fly. This comprehensive “connectome” provides an unprecedented look at how the brain communicates with the body to control movement, behavior, and decision-making.The biggest surprise was that complex behaviors do not appear to be directed by a single central control center. Instead, they emerge from many distributed local neural circuits working together. This discovery challenges traditional views of brain organization and offers valuable insights into how intelligence and coordinated actions arise. The findings could help researchers better understand human brain function and inspire more advanced artificial intelligence systems in the future.

Scientists have identified a promising new way to overcome one of cancer treatment’s biggest challenges: drug resistance. Cancer cells often evade therapy by repairing the DNA damage caused by treatment, allowing them to survive and continue growing.Researchers discovered that a compound called UNI418 can block this DNA repair process, leaving cancer cells more vulnerable to attack. When UNI418 was combined with a PARP inhibitor—a class of cancer drugs that targets DNA repair pathways—previously resistant cancer cells became sensitive to treatment once again.The findings highlight a potential new therapeutic approach that could improve the effectiveness of existing cancer treatments and help patients whose tumors have stopped responding to current therapies.

A new study has revealed a hidden driver of cellular aging: declining levels of phosphatidylcholine, a vital nutrient found in cell membranes. Researchers discovered that as phosphatidylcholine levels decrease with age, mitochondria — the cell’s energy-producing structures — become less efficient, leading to reduced cellular energy and function.The exciting part? Scientists found that restoring phosphatidylcholine levels significantly improved mitochondrial performance in aging organisms, making cells behave more like their younger counterparts. The findings suggest that some aspects of the aging process may not be permanent and could potentially be slowed, or even partially reversed, through targeted interventions. This breakthrough opens promising new avenues for healthy aging and age-related disease research.

In a groundbreaking study, scientists have genetically engineered hookworms to produce and deliver therapeutic molecules from inside a living host. Using CRISPR gene-editing technology, researchers modified the parasite Ancylostoma ceylanicum to secrete an antibody capable of partially neutralizing tetrodotoxin, the deadly poison found in pufferfish.Tests in hamsters showed that the engineered worms successfully released the antitoxin into the bloodstream, demonstrating a completely new approach to drug delivery. Researchers believe future versions could be designed to treat chronic conditions such as inflammatory bowel disease, food allergies, and type 2 diabetes. Because hookworm infections can be easily controlled and eliminated with standard treatments, this innovative technology could open the door to a new generation of living, self-sustaining medicines.

In a groundbreaking achievement, scientists have successfully translated and uploaded the complete genome of the hepatitis D virus (HDV) onto IBM’s 156-qubit Heron quantum computer. This marks the first time a real viral genome has been encoded in a quantum-compatible format for analysis.The research team demonstrated key genomic tasks, including DNA sequence alignment, pangenome assembly, and evolutionary mapping, directly on quantum hardware. Researchers believe quantum computing could eventually tackle complex biological problems that overwhelm even advanced classical computers and AI systems.While practical applications are still years away, this milestone could pave the way for faster disease tracking, improved rare disease research, and more efficient identification of disease-causing mutations, opening a new era in genomics and precision medicine.

Many people expect the scale to drop quickly after replacing sugary soft drinks with juice, coconut water, or zero-sugar alternatives. However, experts say weight loss is often more complex than a single dietary swap. While reducing sugar-sweetened beverages can lower calorie intake and support better health, lasting weight loss depends on overall eating habits, physical activity, and total daily calorie consumption. In some cases, people may unknowingly compensate by consuming extra calories elsewhere or choosing “healthy” drinks that still contain significant amounts of sugar. According to specialists, replacing sugary beverages is a positive first step, but meaningful and sustainable weight loss requires a broader approach focused on long-term lifestyle changes.

A new study from Delhi suggests that the age-old belief that almonds are good for the brain may have scientific backing. Researchers found that middle-aged adults who consumed a daily handful of almonds for 24 weeks showed improvements in thinking speed, concentration, decision-making, and mental agility. The randomized controlled trial, published in The Journal of Nutrition, involved 60 prediabetic Asian Indian adults. Beyond cognitive benefits, participants who ate almonds also experienced better blood sugar control, reduced inflammation, and modest weight loss compared to those on a calorie-matched control diet. The findings highlight almonds as a simple dietary addition that may support both brain and metabolic health.

Many people undergoing chemotherapy experience “chemo brain,” a condition that can affect memory, focus, and everyday thinking skills. A new clinical trial suggests that a simple home-based exercise program may help reduce these cognitive challenges. Researchers found that cancer patients who followed regular exercise routines showed better attention and reported fewer noticeable cognitive problems compared to those receiving a placebo. The study also found that low-dose ibuprofen improved certain cognitive measures, although the benefits were less consistent than those seen with exercise. These findings highlight the potential of physical activity as a practical, low-cost strategy to support brain health during cancer treatment.

A new study has raised concerns about glucosamine, a widely used supplement for joint pain and arthritis. Researchers found that people with mild cognitive impairment who regularly used glucosamine were about 25% more likely to progress to Alzheimer’s disease compared to non-users. The study also identified potential biological mechanisms that may help explain this association, although the exact cause-and-effect relationship remains unclear. Experts stress that the findings do not prove glucosamine causes Alzheimer’s, and more research is needed to confirm the results. However, the study highlights the importance of evaluating the long-term effects of commonly used supplements, especially among older adults at risk of cognitive decline.

A persistent headache, occasional dizziness, memory lapses, or unexplained fatigue are often blamed on stress, lack of sleep, or migraines. However, experts warn that in some cases these symptoms can signal a brain tumour. While most headaches are not cancer-related, warning signs such as worsening headaches, seizures, vision changes, balance problems, speech difficulties, or sudden changes in behavior should not be ignored. Early diagnosis is crucial, as it can improve treatment options and outcomes. Advances in minimally invasive surgery, AI-assisted navigation, and precision diagnostics are also transforming brain tumour care, helping patients recover faster and improving survival rates.